To test the potential efficacy of combining PARPi with KP372-1, we examined the synergistic effect of various PARPi with KP372-1 in A549 NSCLC cells that have low PARP1 expression (Figure S1F). This evidence concerns the gene PARP1 and non-small cell lung carcinoma.